CSI is proud to drive progress and celebrate the power of diversity. Our team is as global as the studies we support. Representing a...

In an industry where both timelines and budgets are under constant pressure, clinical trial sponsors and CROs are often forced to balance...

ASCO 2025 Signals a New Chapter in Myelofibrosis Care The 2025 ASCO Annual Meeting delivered early visibility into where the...

Earlier this month, the US President signed a landmark executive order aimed at delivering “most favored nation” (MFN) pricing for...

We’re incredibly proud to announce that CSI has once again achieved the Platinum   EcoVadis  rating, for the second year in a row!  This places us in the top 1% globally for sustainability, ethics and corporate responsibility. It’s an incredible accomplishment and a testament to the values we live by every day. A huge thank you to our dedicated team for making this possible, your commitment continues to set us apart.

In clinical trials, every element of the supply chain matters. From sourcing high-quality comparator drugs to managing timelines across...

Request A global listed Biotech company required large quantities of Eylea Pre-Filled Syringes (PFS)  sourced across both the EU and USA...

So are we! We’re pleased to share that Jonathan Miller , CSI’s Head of Operations, North America , will be attending Jefferies New York...

Client Request A leading global biopharmaceutical company approached CSI with an urgent need for the Fluarix QIV Southern Hemisphere...

CSI’s Strategic Approach to Mitigating Clinical Trial Supply Disruption Recent developments in U.S. trade policy are shaking up supply...

We’re proud to share that CSI is now fully registered and qualified with  SAM.gov  and BARDA , enabling us to support U.S....